Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: Malignant or benign pathology? Report of a case

Tatyan Clarke, Lea Matsuoka, Nicolas Jabbour, Rodrigo Mateo, Yuri Genyk, Rick Selby, Singh Gagandeep*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Tumor markers such as carbohydrate antigen 19-9 (CA 19-9) are commonly measured in the serum of patients with suspected pancreaticobiliary malignancies. Moderate elevations of CA 19-9 may be seen in benign disease, but levels in the thousands are indicative of malignancy. We report the case of a 64-year-old man with an elevated CA 19-9 of 5791 U/ml and radiological findings suggestive of metastatic gallbladder carcinoma. The patient underwent cholecystectomy and excision of a common bile duct stricture, with hepaticojejunostomy and liver biopsy. The final surgical pathology was consistent with xanthogranulomatous cholecystitis (XGC) and the elevated CA 19-9 returned to normal postoperatively. Thus, an elevated CA 19-9 level, even in the thousands, should not preclude patients from an operation if a mass is deemed resectable. Thorough investigation and treatment may result in a curative operation even if unresectable malignant disease is initially suspected.

Original languageEnglish
Pages (from-to)342-344
Number of pages3
JournalSurgery Today
Volume37
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Keywords

  • Cholecystectomy
  • Gallbladder disease
  • Tumor marker

Fingerprint

Dive into the research topics of 'Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: Malignant or benign pathology? Report of a case'. Together they form a unique fingerprint.

Cite this